- Home
- VATE vs SER Comparison
VATE vs SER Comparison
Compare VATE & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- SER
- Stock Information
- Founded
- VATE 1994
- SER 2017
- Country
- VATE United States
- SER United States
- Employees
- VATE N/A
- SER N/A
- Industry
- VATE Metal Fabrications
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- SER Health Care
- Exchange
- VATE Nasdaq
- SER Nasdaq
- Market Cap
- VATE 63.2M
- SER 56.5M
- IPO Year
- VATE 1996
- SER 2018
- Fundamental
- Price
- VATE $4.69
- SER $5.40
- Analyst Decision
- VATE
- SER Strong Buy
- Analyst Count
- VATE 0
- SER 2
- Target Price
- VATE N/A
- SER $13.00
- AVG Volume (30 Days)
- VATE 29.1K
- SER 25.7K
- Earning Date
- VATE 08-05-2025
- SER 08-11-2025
- Dividend Yield
- VATE N/A
- SER N/A
- EPS Growth
- VATE N/A
- SER N/A
- EPS
- VATE N/A
- SER N/A
- Revenue
- VATE $995,000,000.00
- SER $130,000.00
- Revenue This Year
- VATE N/A
- SER N/A
- Revenue Next Year
- VATE N/A
- SER N/A
- P/E Ratio
- VATE N/A
- SER N/A
- Revenue Growth
- VATE N/A
- SER N/A
- 52 Week Low
- VATE $3.25
- SER $3.81
- 52 Week High
- VATE $13.79
- SER $10.28
- Technical
- Relative Strength Index (RSI)
- VATE 41.27
- SER 48.70
- Support Level
- VATE $4.40
- SER $5.02
- Resistance Level
- VATE $5.21
- SER $5.63
- Average True Range (ATR)
- VATE 0.57
- SER 0.40
- MACD
- VATE -0.09
- SER 0.02
- Stochastic Oscillator
- VATE 11.89
- SER 29.03
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.